MDR 3.45% 30.0¢ medadvisor limited

Social Media, page-100

  1. 3,108 Posts.
    lightbulb Created with Sketch. 84
    I’m only expecting another modest quarter, like March.

    H1FY19 should see the first revenue from the integration with EBOS companies Zest and HPS.

    H2FY19 (2019) can hopefully benefit from some cash through pilots with the 10,000 US pharmacies under PDX.

    I could be wrong and the June quarter might be better than expected. If the numbers might show decline, one would expect a sell off prior to reporting.

    Very little traded yesterday and today so it’s possible everyone is holding tight with the expectation of a positive update.

    The quarterly could come out as soon as next week but I’m expecting the following Monday which is when June 2017 was announced.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.010(3.45%)
Mkt cap ! $215.0M
Open High Low Value Volume
29.0¢ 30.0¢ 27.5¢ $254.8K 889.6K

Buyers (Bids)

No. Vol. Price($)
2 39326 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 2917 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.